{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:03:16Z","timestamp":1761948196030,"version":"build-2065373602"},"reference-count":153,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T00:00:00Z","timestamp":1471910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG13055","IG17475"],"award-info":[{"award-number":["IG13055","IG17475"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2013-0865"],"award-info":[{"award-number":["2013-0865"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Health","award":["RC 2013-2016"],"award-info":[{"award-number":["RC 2013-2016"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Epithelial ovarian cancer (EOC) is the deadliest tumor among gynecological cancer in the industrialized countries. The EOC incidence and mortality have remained unchanged over the last 30 years, despite the progress in diagnosis and treatment. In order to develop novel and more effective therapeutic approaches, the molecular mechanisms involved in EOC progression have been thoroughly investigated in the last few decades. At the late stage, peritoneal metastases originate from the attachment of small clusters of cancer cells that shed from the primary site and carried by the ascites adhere to the abdominal peritoneum or omentum. This behavior suggests that cell\u2013cell or cell\u2013matrix adhesion mechanisms regulate EOC growth and dissemination. Complex downstream signalings, which might be influenced by functional cross-talk between adhesion molecules and co-expressed and activated signaling proteins, can affect the proliferation\/survival and the migration\/invasion of EOC cells. This review aimed to define the impact of the mechanisms of cell\u2013cell, through cadherins, and cell\u2013extracellular matrix adhesion, through integrins, on the signaling cascades induced by membrane receptors and cytoplasmic proteins known to have a role in the proliferation, migration and invasion of EOC cells. Finally, some novel approaches using peptidomimetic ligands to cadherin and integrins are summarized.<\/jats:p>","DOI":"10.3390\/ijms17091387","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T10:18:55Z","timestamp":1471947535000},"page":"1387","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells"],"prefix":"10.3390","volume":"17","author":[{"given":"Francesca","family":"Roggiani","sequence":"first","affiliation":[{"name":"Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, Milan 20133, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delia","family":"Mezzanzanica","sequence":"additional","affiliation":[{"name":"Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, Milan 20133, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Rea","sequence":"additional","affiliation":[{"name":"Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, Milan 20133, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonella","family":"Tomassetti","sequence":"additional","affiliation":[{"name":"Unit of Molecular Therapies, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, Milan 20133, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2016,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3322\/caac.20113","article-title":"Recent progress in the diagnosis and treatment of ovarian cancer","volume":"61","author":"Jelovac","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/AOG.0b013e318264f794","article-title":"Ten-year relative survival for epithelial ovarian cancer","volume":"120","author":"Baldwin","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: Recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_6","unstructured":"(2012). The Cancer Genome Atlas Database, Available online: https:\/\/tcga-data.nci.nih.gov\/."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: A pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ygyno.2011.10.001","article-title":"The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations","volume":"124","author":"Munksgaard","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"ref_9","first-page":"151","article-title":"Pathogenesis of ovarian cancer: Lessons from morphology and molecular biology and their clinical implications","volume":"27","author":"Kurman","year":"2008","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1158\/1078-0432.CCR-05-0508","article-title":"Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer","volume":"11","author":"Zorn","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer","volume":"15","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrc3432","article-title":"Meeting the challenge of ascites in ovarian cancer: New avenues for therapy and research","volume":"13","author":"Kipps","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fonc.2013.00256","article-title":"Getting to know ovarian cancer ascites: Opportunities for targeted therapy-based translational research","volume":"3","author":"Ahmed","year":"2013","journal-title":"Front. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","article-title":"Mechanisms of transcoelomic metastasis in ovarian cancer","volume":"7","author":"Tan","year":"2006","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-2-23","article-title":"Peritoneal inflammation\u2014A microenvironment for Epithelial Ovarian Cancer (EOC)","volume":"2","author":"Freedman","year":"2004","journal-title":"J. Transl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","article-title":"Hematogenous metastasis of ovarian cancer: Rethinking mode of spread","volume":"26","author":"Pradeep","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_17","first-page":"490","article-title":"An electron microscopy study of the invasion of ascites tumor cells into the abdominal wall","volume":"25","author":"Birbeck","year":"1965","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-3163-6-11","article-title":"\u03b12\u03b21 Integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis","volume":"6","author":"Shield","year":"2007","journal-title":"J. Carcinog."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10585-004-5768-5","article-title":"Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers","volume":"21","author":"Burleson","year":"2004","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1158\/2159-8274.CD-11-0010","article-title":"Ovarian cancer spheroids use myosin-generated force to clear the mesothelium","volume":"1","author":"Iwanicki","year":"2011","journal-title":"Cancer Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-0-387-98094-2_15","article-title":"Microenvironmental regulation of ovarian cancer metastasis","volume":"149","author":"Barbolina","year":"2009","journal-title":"Cancer Treat. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/cncr.26449","article-title":"Adhesion molecule protein signature in ovarian cancer effusions is prognostic of patient outcome","volume":"118","author":"Kim","year":"2012","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrm3802","article-title":"Dynamic contacts: Rearranging adherens junctions to drive epithelial remodelling","volume":"15","author":"Takeichi","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/374327a0","article-title":"Structural basis of cell-cell adhesion by cadherins","volume":"374","author":"Shapiro","year":"1995","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6708","DOI":"10.1074\/jbc.M109640200","article-title":"E-cadherin homophilic ligation directly signals through Rac and phosphatidylinositol 3-kinase to regulate adhesive contacts","volume":"277","author":"Kovacs","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"C1061","DOI":"10.1152\/ajpcell.00073.2006","article-title":"Rac is a dominant regulator of cadherin-directed actin assembly that is activated by adhesive ligation independently of Tiam1","volume":"292","author":"Kraemer","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1242\/jcs.114.10.1829","article-title":"Recruitment and activation of Rac1 by the formation of E-cadherin-mediated cell-cell adhesion sites","volume":"114","author":"Nakagawa","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1083\/jcb.200701058","article-title":"Localized zones of Rho and Rac activities drive initiation and expansion of epithelial cell-cell adhesion","volume":"178","author":"Yamada","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"36999","DOI":"10.1074\/jbc.M003430200","article-title":"E-cadherin-mediated cell-cell attachment activates Cdc42","volume":"275","author":"Kim","year":"2000","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/35103068","article-title":"Rho-family GTPases in cadherin-mediated cell-cell adhesion","volume":"2","author":"Fukata","year":"2001","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0955-0674(03)00101-7","article-title":"Cadherin-mediated cellular signaling","volume":"15","author":"Wheelock","year":"2003","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1083\/jcb.201008173","article-title":"Evolution: Structural and functional diversity of cadherin at the adherens junction","volume":"193","author":"Oda","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/onc.2014.136","article-title":"Epithelial-mesenchymal status renders differential responses to cisplatin in ovarian cancer","volume":"34","author":"Miow","year":"2014","journal-title":"Oncogene"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ccr.2013.03.004","article-title":"Tumor dissemination: An EMT affair","volume":"23","author":"Thiery","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/B978-0-12-394311-8.00014-5","article-title":"Cadherins and epithelial-to-mesenchymal transition","volume":"116","author":"Gheldof","year":"2013","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1083\/jcb.200212033","article-title":"Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin","volume":"161","author":"Wong","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1038\/sj.emboj.7600136","article-title":"E-cadherin-mediated adhesion inhibits ligand-dependent activation of diverse receptor tyrosine kinases","volume":"23","author":"Qian","year":"2004","journal-title":"EMBO J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4161\/cbt.4.1.1431","article-title":"No one-way street: Cross-talk between e-cadherin and receptor tyrosine kinase (RTK) signaling: A mechanism to regulate RTK activity","volume":"4","author":"Andl","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature15748","article-title":"Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance","volume":"527","author":"Fischer","year":"2015","journal-title":"Nature"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature16064","article-title":"Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer","volume":"527","author":"Zheng","year":"2015","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1172\/JCI57100","article-title":"Breast cancer\u2014One term, many entities?","volume":"121","author":"Bertos","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/sj.bjc.6600807","article-title":"Inflammatory breast cancer shows angiogenesis with high endothelial proliferation rate and strong E-cadherin expression","volume":"88","author":"Colpaert","year":"2003","journal-title":"Br. J. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029","article-title":"Collective invasion in breast cancer requires a conserved basal epithelial program","volume":"155","author":"Cheung","year":"2013","journal-title":"Cell"},{"key":"ref_45","first-page":"E2595","article-title":"ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium","volume":"109","author":"Cheung","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0046-8177(97)90007-1","article-title":"Expression of cadherins in benign, borderline, and malignant ovarian epithelial tumors: A clinicopathologic study of 60 cases","volume":"28","author":"Darai","year":"1997","journal-title":"Hum. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.1998.00341.x","article-title":"Expression of E-cadherin, \u03b1-catenin and \u03b2-catenin in normal ovarian surface epithelium and epithelial ovarian cancers","volume":"32","author":"Davies","year":"1998","journal-title":"Histopathology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<275::AID-IJC7>3.0.CO;2-W","article-title":"E-cadherin expression in human epithelial ovarian cancer and normal ovary","volume":"74","author":"Sundfeldt","year":"1997","journal-title":"Int. J. Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.humpath.2004.09.014","article-title":"Elevated expression of E-cadherin and \u03b1-, \u03b2-, and \u03b3-catenins in metastatic lesions compared with primary epithelial ovarian carcinomas","volume":"35","author":"Imai","year":"2004","journal-title":"Hum. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1083\/jcb.200212114","article-title":"Differential regulation of cell motility and invasion by FAK","volume":"160","author":"Hsia","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1593\/neo.81004","article-title":"Variant HNF1 modulates epithelial plasticity of normal and transformed ovary cells","volume":"10","author":"Tomassetti","year":"2008","journal-title":"Neoplasia"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Strauss, R., Li, Z.Y., Liu, Y., Beyer, I., Persson, J., Sova, P., Moller, T., Pesonen, S., Hemminki, A., and Hamerlik, P. (2011). Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity. PLoS ONE, 6.","DOI":"10.1371\/annotation\/8c637352-3614-406c-89dc-e78d10fa069c"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1038\/srep05646","article-title":"Construction and characteristics of an E-cadherin-related three-dimensional suspension growth model of ovarian cancer","volume":"4","author":"Xu","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1210\/me.2004-0342","article-title":"Formation of E-cadherin-mediated cell-cell adhesion activates AKT and mitogen activated protein kinase via phosphatidylinositol 3 kinase and ligand-independent activation of epidermal growth factor receptor in ovarian cancer cells","volume":"19","author":"Reddy","year":"2005","journal-title":"Mol. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ceb.2005.08.001","article-title":"Molecular requirements for epithelial-mesenchymal transition during tumor progression","volume":"17","author":"Huber","year":"2005","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/aps.2012.30","article-title":"E-cadherin promotes proliferation of human ovarian cancer cells in vitro via activating MEK\/ERK pathway","volume":"33","author":"Dong","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1083\/jcb.200307111","article-title":"A core function for p120-catenin in cadherin turnover","volume":"163","author":"Davis","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9182","DOI":"10.1073\/pnas.0500918102","article-title":"ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and \u03b2-catenin translocation","volume":"102","author":"Maretzky","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1242\/jcs.114.1.111","article-title":"Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1","volume":"114","author":"Noe","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/emboj\/21.8.1948","article-title":"A presenilin-1\/\u03b3-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions","volume":"21","author":"Marambaud","year":"2002","journal-title":"EMBO J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.10-0157","article-title":"Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers","volume":"138","author":"Gogali","year":"2010","journal-title":"Chest"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1158\/0008-5472.CAN-07-5046","article-title":"Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent E-cadherin loss in ovarian carcinoma cells","volume":"68","author":"Symowicz","year":"2008","journal-title":"Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1158\/0008-5472.CAN-06-2808","article-title":"Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells","volume":"67","author":"Symowicz","year":"2007","journal-title":"Cancer Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/bjc.2015.436","article-title":"E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer","volume":"114","author":"Trillsch","year":"2016","journal-title":"Br. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0002-9440(10)65146-2","article-title":"Changing roles of cadherins and catenins during progression of squamous intraepithelial lesions in the uterine cervix","volume":"155","author":"van","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_66","first-page":"135","article-title":"Altered cadherin and catenin complexes in the Barrett\u2019s esophagus-dysplasia-adenocarcinoma sequence: Correlation with disease progression and dedifferentiation","volume":"152","author":"Bailey","year":"1998","journal-title":"Am. J. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.0.CO;2-2","article-title":"P-cadherin expression in breast carcinoma indicates poor survival","volume":"86","author":"Peralta","year":"1999","journal-title":"Cancer"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/gut.50.4.513","article-title":"Aberrant P-cadherin expression is an early event in hyperplastic and dysplastic transformation in the colon","volume":"50","author":"Hardy","year":"2002","journal-title":"Gut"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/ijc.11086","article-title":"Cadherin switching in ovarian cancer progression","volume":"106","author":"Patel","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1038\/onc.2009.523","article-title":"Cadherin switching and activation of p120 catenin signaling are mediators of gonadotropin-releasing hormone to promote tumor cell migration and invasion in ovarian cancer","volume":"29","author":"Cheung","year":"2010","journal-title":"Oncogene"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1038\/onc.2011.7","article-title":"P-cadherin cooperates with insulin-like growth factor-1 receptor to promote metastatic signaling of gonadotropin-releasing hormone in ovarian cancer via p120 catenin","volume":"30","author":"Cheung","year":"2011","journal-title":"Oncogene"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/mt.2012.187","article-title":"Targeting gonadotropin-releasing hormone receptor inhibits the early step of ovarian cancer metastasis by modulating tumor-mesothelial adhesion","volume":"21","author":"Cheung","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1158\/1541-7786.MCR-13-0489","article-title":"P-cadherin promotes ovarian cancer dissemination through tumor cell aggregation and tumor-peritoneum interactions","volume":"12","author":"Usui","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.18632\/oncotarget.2362","article-title":"p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin\/\u03b21 integrin signaling activation","volume":"5","author":"Ip","year":"2014","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00441-009-0834-6","article-title":"Integrins","volume":"339","author":"Barczyk","year":"2010","journal-title":"Cell Tissue Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","article-title":"RGD and other recognition sequences for integrins","volume":"12","author":"Ruoslahti","year":"1996","journal-title":"Annu. Rev. Cell Biol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.addr.2010.11.001","article-title":"Focal adhesion kinase and its signaling pathways in cell migration and angiogenesis","volume":"63","author":"Zhao","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/372786a0","article-title":"Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase","volume":"372","author":"Schlaepfer","year":"1994","journal-title":"Nature"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/CBI20090331","article-title":"Mesothelial vitronectin stimulates migration of ovarian cancer cells","volume":"34","author":"Heyman","year":"2010","journal-title":"Cell Biol. Int."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","article-title":"Loss of E-cadherin promotes ovarian cancer metastasis via \u03b1 5-integrin, which is a therapeutic target","volume":"68","author":"Sawada","year":"2008","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/carcin\/23.2.237","article-title":"Overexpression of \u03b1v\u03b26 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade","volume":"23","author":"Ahmed","year":"2002","journal-title":"Carcinogenesis"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.yexcr.2013.11.011","article-title":"Cell cycle arrest or survival signaling through \u03b1v integrins, activation of PKC and ERK1\/2 lead to anoikis resistance of ovarian cancer spheroids","volume":"320","author":"Carduner","year":"2014","journal-title":"Exp. Cell Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10585-014-9658-1","article-title":"Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: Enhancement of their invasive behavior partly dependant on \u03b1v integrins","volume":"31","author":"Carduner","year":"2014","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fonc.2015.00245","article-title":"The Extracellular matrix in epithelial ovarian cancer\u2014A piece of a Puzzle","volume":"5","author":"Cho","year":"2015","journal-title":"Front. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1172\/JCI74778","article-title":"Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion","volume":"124","author":"Kenny","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cbin.10184","article-title":"Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K\/Akt pathway","volume":"38","author":"Yousif","year":"2014","journal-title":"Cell Biol. Int."},{"key":"ref_88","first-page":"4261","article-title":"Association between fibronectin expression and prognosis in ovarian carcinoma","volume":"23","author":"Franke","year":"2003","journal-title":"Anticancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: Biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-cellbio-092910-154017","article-title":"Cooperation between integrins and growth factor receptors in signaling and endocytosis","volume":"27","author":"Ivaska","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.3390\/cancers7030860","article-title":"Targeting RTK signaling pathways in cancer","volume":"7","author":"Regad","year":"2015","journal-title":"Cancers"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1476-4598-10-125","article-title":"Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation","volume":"10","author":"Jiao","year":"2011","journal-title":"Mol. Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrm1962","article-title":"EGF-ERBB signalling: Towards the systems level","volume":"7","author":"Citri","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1093\/emboj\/17.22.6622","article-title":"Integrins induce activation of EGF receptor: Role in MAP kinase induction and adhesion-dependent cell survival","volume":"17","author":"Moro","year":"1998","journal-title":"EMBO J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1083\/jcb.200105017","article-title":"EGF-R signaling through Fyn kinase disrupts the function of integrin \u03b16\u03b24 at hemidesmosomes: Role in epithelial cell migration and carcinoma invasion","volume":"155","author":"Mariotti","year":"2001","journal-title":"J. Cell Biol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.1074\/jbc.M109101200","article-title":"Integrin-induced epidermal growth factor (EGF) receptor activation requires c-Src and p130Cas and leads to phosphorylation of specific EGF receptor tyrosines","volume":"277","author":"Moro","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1042\/bst0320438","article-title":"Integrin regulation of epidermal growth factor (EGF) receptor and of EGF-dependent responses","volume":"32","author":"Cabodi","year":"2004","journal-title":"Biochem. Soc. Trans."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.canep.2012.06.005","article-title":"The epidermal growth factor receptor as a therapeutic target in epithelial ovarian cancer","volume":"36","author":"Gui","year":"2012","journal-title":"Cancer Epidemiol."},{"key":"ref_99","first-page":"232","article-title":"Clinical implications of the ErbB\/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer","volume":"1785","author":"Lafky","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1038\/onc.2011.572","article-title":"Ligand-dependent EGFR activation induces the co-expression of IL-6 and PAI-1 via the NF\u03baB pathway in advanced-stage epithelial ovarian cancer","volume":"31","author":"Alberti","year":"2012","journal-title":"Oncogene"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/jnci\/93.18.1375","article-title":"Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells","volume":"93","author":"Alper","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"9280","DOI":"10.1158\/0008-5472.CAN-05-0407","article-title":"Down-regulation of integrin \u03b12 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation","volume":"65","author":"Ning","year":"2005","journal-title":"Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1038\/35083116","article-title":"Pathway specificity for Met signalling","volume":"3","author":"Comoglio","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/0008-5472.CAN-06-1147","article-title":"c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion","volume":"67","author":"Sawada","year":"2007","journal-title":"Cancer Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2010.532","article-title":"Ligand-independent activation of c-Met by fibronectin and \u03b15\u03b21-integrin regulates ovarian cancer invasion and metastasis","volume":"30","author":"Mitra","year":"2011","journal-title":"Oncogene"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/onc.2013.539","article-title":"Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment","volume":"34","author":"Kwon","year":"2015","journal-title":"Oncogene"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"11749","DOI":"10.1038\/srep11749","article-title":"INC280, an orally available small molecule inhibitor of c-MET, reduces migration and adhesion in ovarian cancer cell models","volume":"5","author":"Brown","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrd1381","article-title":"Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer","volume":"3","author":"Ferrara","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1349-7006.1996.tb02127.x","article-title":"Inhibition of growth and metastasis of ovarian carcinoma by administering a drug capable of interfering with vascular endothelial growth factor activity","volume":"87","author":"Mu","year":"1996","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/bjc.1997.537","article-title":"Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels","volume":"76","author":"Yamamoto","year":"1997","journal-title":"Br. J. Cancer"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/cvr\/cvn045","article-title":"Besides adhesion: New perspectives of integrin functions in angiogenesis","volume":"78","author":"Serini","year":"2008","journal-title":"Cardiovasc. Res."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.4161\/cbt.8.23.10134","article-title":"Combined anti-angiogenic therapy against VEGF and integrin \u03b1v\u03b23 in an orthotopic model of ovarian cancer","volume":"8","author":"Kim","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1593\/neo.08740","article-title":"Tumor-selective response to antibody-mediated targeting of \u03b1v\u03b23 integrin in ovarian cancer","volume":"10","author":"Landen","year":"2008","journal-title":"Neoplasia"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/jclinpath-2016-203629","article-title":"Gene of the month: Axl.","volume":"69","author":"Brown","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/ng.2330","article-title":"Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer","volume":"44","author":"Zhang","year":"2012","journal-title":"Nat. Genet."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","article-title":"An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance","volume":"19","author":"Byers","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0065-230X(08)00002-X","article-title":"TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer","volume":"100","author":"Linger","year":"2008","journal-title":"Adv. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1042\/CS20110411","article-title":"Axl-dependent signalling: A clinical update","volume":"122","author":"Korshunov","year":"2012","journal-title":"Clin. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000079499","article-title":"Coexpression of Gas6\/Axl in human ovarian cancers","volume":"66","author":"Sun","year":"2004","journal-title":"Oncology"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"238284","DOI":"10.1155\/2013\/238284","article-title":"Meta-analysis of microarray data identifies GAS6 expression as an independent predictor of poor survival in ovarian cancer","volume":"2013","author":"Buehler","year":"2013","journal-title":"BioMed Res. Int."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"7570","DOI":"10.1158\/0008-5472.CAN-10-1267","article-title":"Axl is an essential factor and therapeutic target for metastatic ovarian cancer","volume":"70","author":"tRankin","year":"2010","journal-title":"Cancer Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"30859","DOI":"10.18632\/oncotarget.5087","article-title":"Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome","volume":"6","author":"Rea","year":"2015","journal-title":"Oncotarget"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/sj.onc.1204178","article-title":"Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27","volume":"20","author":"Acquati","year":"2001","journal-title":"Oncogene"},{"key":"ref_124","first-page":"1159","article-title":"Tumor and metastasis suppression by the human RNASET2 gene","volume":"26","author":"Acquati","year":"2005","journal-title":"Int. J. Oncol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"8140","DOI":"10.1073\/pnas.1222079110","article-title":"Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis","volume":"110","author":"Acquati","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.18632\/oncotarget.3490","article-title":"Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase","volume":"6","author":"Lualdi","year":"2015","journal-title":"Oncotarget"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1002\/cncr.22327","article-title":"A recombinant human RNASET2 glycoprotein with antitumorigenic and antiangiogenic characteristics: Expression, purification, and characterization","volume":"107","author":"Smirnoff","year":"2006","journal-title":"Cancer"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"11464","DOI":"10.18632\/oncotarget.2562","article-title":"Human recombinant truncated RNASET2, devoid of RNase activity; A potential cancer therapeutic agent","volume":"5","author":"Schwartz","year":"2014","journal-title":"Oncotarget"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3892\/or.2014.3175","article-title":"Downregulation of tumor suppressor gene ribonuclease T2 and gametogenetin binding protein 2 is associated with drug resistance in ovarian cancer","volume":"32","author":"Yin","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2014.07.009","article-title":"Focal adhesion signaling and therapy resistance in cancer","volume":"31","author":"Eke","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","article-title":"Integrins and cancer: Regulators of cancer stemness, metastasis, and drug resistance","volume":"25","author":"Seguin","year":"2015","journal-title":"Trends Cell Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/cmmi.444","article-title":"A new optical imaging probe targeting \u03b1v\u03b23 integrin in glioblastoma xenografts","volume":"6","author":"Lanzardo","year":"2011","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/cmdc.201200043","article-title":"Synthesis of Gd and 68Ga complexes in conjugation with a conformationally optimized RGD sequence as potential MRI and PET tumor-imaging probes","volume":"7","author":"Manzoni","year":"2012","journal-title":"ChemMedChem"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1021\/bc300164t","article-title":"Design, synthesis, and biological evaluation of novel cRGD-paclitaxel conjugates for integrin-assisted drug delivery","volume":"23","author":"Arosio","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"10460","DOI":"10.1021\/jm301058f","article-title":"Synthesis and biological evaluation (in vitro and in vivo) of cyclic arginine-glycine-aspartate (RGD) peptidomimetic-paclitaxel conjugates targeting integrin \u03b1v\u03b23","volume":"55","author":"Colombo","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"915140","DOI":"10.1155\/2012\/915140","article-title":"Integrin inhibitors as a therapeutic agent for ovarian cancer","volume":"2012","author":"Sawada","year":"2012","journal-title":"J. Oncol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1470-2045(14)70379-1","article-title":"Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071\u201322072 study): A multicentre, randomised, open-label, phase 3 trial","volume":"15","author":"Stupp","year":"2014","journal-title":"Lancet Oncol."},{"key":"ref_138","unstructured":"Merck Press Release on Cilengitide Studies. Available online: http:\/\/www.merck.de\/de\/press\/extNewsDetail.html?newsId=C47977D13865FCB9C1257B1D001EF9CA&newsType=1."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.addr.2015.12.001","article-title":"Advancement in integrin facilitated drug delivery","volume":"97","author":"Arosio","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00441-011-1320-5","article-title":"Discovery and development of N-cadherin antagonists","volume":"348","author":"Blaschuk","year":"2012","journal-title":"Cell Tissue Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1158\/0008-5472.CAN-07-5949","article-title":"Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment","volume":"68","author":"Augustine","year":"2008","journal-title":"Cancer Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1200\/JCO.2010.32.1224","article-title":"Prospective Multicenter Phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma","volume":"29","author":"Beasley","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1093\/annonc\/mdn695","article-title":"Clinical and pharmacological phase I evaluation of Exherin (ADH-1), a selective anti-N-cadherin peptide in patients with N-cadherin-expressing solid tumours","volume":"20","author":"Perotti","year":"2009","journal-title":"Ann. Oncol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/SLA.0000000000000635","article-title":"Targeting N-cadherin increases vascular permeability and differentially activates AKT in melanoma","volume":"261","author":"Turley","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1039\/C4OB02538E","article-title":"Computational design of novel peptidomimetic inhibitors of cadherin homophilic interactions","volume":"13","author":"Doro","year":"2015","journal-title":"Org. Biomol. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1021\/acs.jmedchem.5b01487","article-title":"Crystal structure of human E-Cadherin-EC1EC2 in complex with a peptidomimetic competitive inhibitor of cadherin homophilic interaction","volume":"59","author":"Nardone","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/jm970832g","article-title":"N-Methylated cyclic RGD peptides as highly active and selective \u03b1V\u03b23 integrin antagonists","volume":"42","author":"Dechantsreiter","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.279.5349.377","article-title":"Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model","volume":"279","author":"Arap","year":"1998","journal-title":"Science"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1002\/cmdc.200800422","article-title":"Cyclic RGD-containing functionalized azabicycloalkane peptides as potent integrin antagonists for tumor targeting","volume":"4","author":"Manzoni","year":"2009","journal-title":"ChemMedChem"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Hou, L., Zhao, X., Wang, P., Ning, Q., Meng, M., and Liu, C. (2013). Antitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0053491"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6265","DOI":"10.1002\/chem.201406567","article-title":"Cyclic isoDGR and RGD peptidomimetics containing bifunctional diketopiperazine scaffolds are integrin antagonists","volume":"21","author":"Panzeri","year":"2015","journal-title":"Chemistry"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5480","DOI":"10.1016\/j.bmc.2011.07.046","article-title":"Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin \u03b1v\u03b26","volume":"19","author":"Li","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ijc.23027","article-title":"ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression","volume":"122","author":"Shintani","year":"2008","journal-title":"Int. J. Cancer"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/9\/1387\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:29:03Z","timestamp":1760210943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/17\/9\/1387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,23]]},"references-count":153,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2016,9]]}},"alternative-id":["ijms17091387"],"URL":"https:\/\/doi.org\/10.3390\/ijms17091387","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2016,8,23]]}}}